Loading organizations...
Lundbeckfonden BioCapital functions as an evergreen venture capital fund, investing in life science companies. It specializes in translating and commercializing groundbreaking scientific discoveries, particularly within the Danish biotech ecosystem. The firm identifies scientific breakthroughs, aiming to facilitate impactful medicine and technology development.
Established in 2009 as Lundbeckfonden Ventures, the fund was created under the larger Lundbeck Foundation. Its inception addressed the need for dedicated capital and strategic support within the burgeoning life science industry. This bridged academic research with market innovation, extending the parent foundation's commitment to advancing health sciences.
The fund partners with early-stage and growth-oriented life science companies. Lundbeckfonden BioCapital’s vision accelerates novel treatment and medical technology development for patient benefit. It transforms research into practical applications, generating societal impact and financial returns supporting the Lundbeck Foundation's philanthropic mission.
